Tryptamine Cowboy Chronicles Episode #3 on the Sacred Synthesis Podcast: First Psilomethoxin Dieta

カートのアイテムが多すぎます

ご購入は五十タイトルがカートに入っている場合のみです。

カートに追加できませんでした。

しばらく経ってから再度お試しください。

ウィッシュリストに追加できませんでした。

しばらく経ってから再度お試しください。

ほしい物リストの削除に失敗しました。

しばらく経ってから再度お試しください。

ポッドキャストのフォローに失敗しました

ポッドキャストのフォロー解除に失敗しました

Tryptamine Cowboy Chronicles Episode #3 on the Sacred Synthesis Podcast: First Psilomethoxin Dieta

無料で聴く

ポッドキャストの詳細を見る

keywords Psilomethoxin, psychedelics, mental health, veterans, community drug development, healing, psilocybin, DMT, psychedelic industry, patents hashtags #psilomethoxin #sacredsynthesis #toadshrooms #bufoboomers #churchofpsilomethoxin #toadally #hikrodosing #psilotoad #toadstool #🐸🍄 summary In this conversation, Psilo Toad and Ryan discuss their experiences with Psilomethoxin, a psychedelic compound derived from mushrooms. They reminisce about their first Dieta experience, compare Psilomethoxin to psilocybin, and explore its potential as a healing tool, especially for veterans. The discussion also touches on the future of the psychedelic industry, community drug development, and the implications of patents related to Psilomethoxin. takeaways Psilomethoxin offers a unique experience compared to traditional psychedelics. The healing process can be simplified for better accessibility. Psilomethoxin can serve as both an on-ramp and off-ramp for other psychedelics. Community drug development is essential for faster access to healing substances. Veterans are finding relief through the use of Psilomethoxin. The psychedelic industry is evolving with new compounds and accessibility. Patents on psychedelics can complicate access and development. Natural mushrooms should be accessible to everyone. The consumer will benefit from more quality products at lower prices. Healing doesn't have to be a painful process. Sound Bites "This is some Jedi magic." "Healing doesn't have to hurt." "Psilomethoxin is also a wonderful on-ramp." Chapters 00:00 Introduction and Setting the Stage 01:14 First Dieta Experience with Psilomethoxin 03:00 Ryan's Background and Journey into Psychedelics 06:46 Comparing Psilomethoxin and Psilocybin 10:48 The Potential of Isolated Psilomethoxin 12:10 Exploring the Afterglow of Psilomethoxin 17:14 Veterans and the Use of Psilomethoxin 24:41 Community Drug Development and Accessibility 30:49 The Future of the Psychedelic Industry 35:45 Closing Thoughts and Reflections

まだレビューはありません